| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR02 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR14 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR03 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR04 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR11 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR12 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR05 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR06 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR17 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR18 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR07 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR08 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR15 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR16 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR02 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR04 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR18 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR20 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR07 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR08 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR23 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR24 | Genotype:PMM2-CDG | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR01 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR13 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR01 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR02 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR09 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR10 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR03 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR04 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR15 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR16 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR05 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR06 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR13 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR14 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR01 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR03 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR17 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR19 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR05 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR06 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR21 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR22 | Genotype:PMM2-CDG | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR08 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR20 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR19 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR20 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR27 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR28 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR11 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR12 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR23 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR24 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR23 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR24 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR31 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR32 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR10 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR12 | Genotype:WT | Treatment:5.5mM 12C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR15 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR16 | Genotype:WT | Treatment:5.5mM 12C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR07 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR19 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR17 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR18 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR25 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR26 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR09 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR10 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR21 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF0000858_SR22 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR21 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR22 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR29 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000887_SR30 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR09 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR11 | Genotype:WT | Treatment:5.5mM 13C Glc negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR13 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | MCF000867_SR14 | Genotype:WT | Treatment:5.5mM 13C Glc siRNA | AUC |
Return to study ST002563 main page
Download data matrix(Metabolomic profiling of PMM2-CDG after siRNA mediated KD of AKR1b1 Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|